February 6, 2023

R. J. Corman Railroad Group, in its 50th Anniversary, Commits Once Again to Support Cancer Research by Donating $50,000 to the Dana Farber Institute

R. J. Corman Railroad Group’s founder Richard J. “Rick” Corman was diagnosed with Multiple Myeloma in 2001 after collapsing during a run. After this diagnosis, Mr. Corman began looking for the best possible treatment, finding the leading center for treatment at Harvard’s “Dana-Farber Cancer Institute.” At the Institute, Mr. Corman met world-renowned cancer researcher Dr. Paul Richardson, who would become his primary physician during his lengthy battle against cancer.

Mr. Corman generously donated funds every year for more research at the institute through the foundation that today bears his name, the “Richard J. Corman Multiple Myeloma Fund.”

After 12 years of battling cancer, on August 23, 2013, Mr. Corman sadly passed away. It is to honor his legacy of generosity that R. J. Corman Railroad Group is committed to supporting cancer research every year.

As a way of celebrating 50 years of history, and through the generous donations of employees, a gift in honor of our friends and customers this past Christmas, and a company donation, R. J. Corman Railroad Group is honored to donate a combined contribution of $50,000 to the “Richard J. Corman Multiple Myeloma Fund.”

Last Friday, Dr. Richardson (now Clinical Program Leader and Director of Clinical Research of the Jerome Lipper Multiple Myeloma Center and R. J. Corman, Professor of Medicine at Harvard Medical School) and Dr. Constantine S. Mitsiades (Associate Professor in Medicine at Harvard Medical School) joined R. J. Corman Railroad Group President and CEO Ed Quinn on a virtual conference call with the company for an update on the advances in their progressive work on cancer research.

R. J. Corman Railroad Group is incredibly grateful for this partnership and the opportunity to allow us to support the battle to cure this terrible disease.

To learn more about Multiple Myeloma and Dana-Farber Cancer Institute, please visit the following link: Dana-Farber Cancer Institute | Multiple Myeloma